← Leaderboards
Yongkui Jing
Mount Sinai School Of Medicine Of Nyu
$3,056,782
Attributed
$3,056,782
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $478.8K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,056,782 · 3
By mechanism
R01$2,226,317 · 1
R21$830,465 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisEnzyme ActivityCell LineGlutathione PeroxidaseHydrogen PeroxideOrganAnimal ModelClinical TrialsPathway InteractionsMediatingToxic EffectSamplingXenograft ProcedureSmall Hairpin RnaIn VivoCellsMalignant NeoplasmsCancer CellTissue /Cell CultureNeoplasm /Cancer ChemotherapyAftercareApoptoticChemotherapyAcute Promyelocytic Leukemia
Grant awards (13)
Arsenic Trioxide and Acute Myeloid Leukemia$247,445
R01 · FY2012 · CA · contact PI
Arsenic Trioxide and Acute Myeloid Leukemia$247,445
R01 · FY2011 · CA · contact PI
Arsenic Trioxide and Acute Myeloid Leukemia$255,098
R01 · FY2010 · CA · contact PI
Targeting prostate cancer by inhibition of mTOR with ezhu oil$186,450
R21 · FY2010 · CA · contact PI
Arsenic Trioxide and Acute Myeloid Leukemia$255,098
R01 · FY2009 · CA · contact PI
Targeting prostate cancer by inhibition of mTOR with ezhu oil$223,740
R21 · FY2009 · CA · contact PI
Arsenic Trioxide and Acute Myeloid Leukemia$255,079
R01 · FY2008 · CA · contact PI
Arsenic Trioxide and Acute Myeloid Leukemia$241,538
R01 · FY2005 · CA
Therapeutic effect of boswellin in prostate cancer$208,400
R21 · FY2005 · AT
Arsenic Trioxide and Acute Myeloid Leukemia$241,538
R01 · FY2004 · CA
Therapeutic effect of boswellin in prostate cancer$211,875
R21 · FY2004 · AT
Arsenic Trioxide and Acute Myeloid Leukemia$241,538
R01 · FY2003 · CA
Arsenic Trioxide and Acute Myeloid Leukemia$241,538
R01 · FY2002 · CA